USFDA issues 11 observations for Sun Pharmaceutical’s Dadra facility

24 Apr 2017 Evaluate

Sun Pharmaceutical Industries has received 11 observations from the United States Food and Drug Administration (USFDA) after inspection of its Dadra facility. This inspection was completed on April 13, 2017. A Form-483 observation letter was issued by the USFDA post the inspection, listing 11 observations.

The company, however, did not provide any details about the observations made by the US health regulator.

The company and its subsidiaries have many facilities which supply products to the US market. These facilities undergo periodic routine inspection by the USFDA in normal course of business.

Sun Pharmaceutical Industries is an Indian multinational pharmaceutical company that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States.

Sun Pharma Inds. Share Price

1673.55 4.35 (0.26%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×